Loading…

LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine

An LC/MS/MS assay was developed and successfully used to quantitate vesnarinone and its principal metabolites (OPC-8230, OPC-18136, and OPC-18137) in human plasma and urine. Samples were pre-treated with liquid–solid extraction followed by simultaneous monitoring of primary and daughter ions which w...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 1999, Vol.18 (6), p.1037-1045
Main Authors: Tata, PrasadN.V., Schorno, KarlS, Cowart, T.Douglas, Bramer, StevenL
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3
cites cdi_FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3
container_end_page 1045
container_issue 6
container_start_page 1037
container_title Journal of pharmaceutical and biomedical analysis
container_volume 18
creator Tata, PrasadN.V.
Schorno, KarlS
Cowart, T.Douglas
Bramer, StevenL
description An LC/MS/MS assay was developed and successfully used to quantitate vesnarinone and its principal metabolites (OPC-8230, OPC-18136, and OPC-18137) in human plasma and urine. Samples were pre-treated with liquid–solid extraction followed by simultaneous monitoring of primary and daughter ions which were used for the identification and quantitation of the analytes on LC/MS/MS. This assay offers advantages of specificity, speed and greater sensitivity over the previously developed HPLC-UV assay. The lower limit of quantitation is 500 ng ml −1 for vesnarinone and 20 ng ml −1 for OPC-8230, OPC-18137, and OPC-18136 in plasma. Methodology is similar for the estimation of these analytes in urine with the lower limit of quantitation being 500 ng ml −1 for vesnarinone and 100 ng ml −1 for each metabolite. Ascorbic acid was added to stabilize the analytes from degradation. This LC/MS/MS method was developed to overcome many practical problems associated with the HPLC method. The LC/MS/MS method offers the flexibility of analyzing additional metabolites and changing the linearity range to accommodate the differences in linear range (200–10 000 ng ml −1 for vesnarinone and 20–1000 for metabolites) for the analytes.
doi_str_mv 10.1016/S0731-7085(98)00194-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69569268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708598001940</els_id><sourcerecordid>69569268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3</originalsourceid><addsrcrecordid>eNqFkEtLxDAQgIMouj5-gtCDiB6qkyZpm5PI4gtWBFfBW8gmU4j0sXa6wv57sw_0KASGZL6ZzHyMnXK44sDz6ykUgqcFlOpCl5cAXMsUdtiIl4VIs1x-7LLRL3LADok-AUBFbJ_ta50pIWHEXifj6-dpPIltbb2kQElXJd9Ire1D27UY330SBkrm8e7C3NZJg4OddXUYkJLQJvPaUmPX3CIyeMz2KlsTnmzjEXu_v3sbP6aTl4en8e0kdVKpIZWIPi7CRSYhdwJ9Jb0q0Tm0yAtQHjBTlfPSZui0mAnlUOeZ0qUtBGgnjtj5pu-8774WSINpAjmsa9tityCTa5XrLC8jqDag6zuiHisTd2lsvzQczMqlWbs0K1FGl2bt0kCsO91-sJg16H-rtvJi_mybt-RsXfU2CqK_5nlRSC4idrPBMMr4DtgbcgFbhz706Abju_DPID_ag5BF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69569268</pqid></control><display><type>article</type><title>LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine</title><source>Elsevier</source><creator>Tata, PrasadN.V. ; Schorno, KarlS ; Cowart, T.Douglas ; Bramer, StevenL</creator><creatorcontrib>Tata, PrasadN.V. ; Schorno, KarlS ; Cowart, T.Douglas ; Bramer, StevenL</creatorcontrib><description>An LC/MS/MS assay was developed and successfully used to quantitate vesnarinone and its principal metabolites (OPC-8230, OPC-18136, and OPC-18137) in human plasma and urine. Samples were pre-treated with liquid–solid extraction followed by simultaneous monitoring of primary and daughter ions which were used for the identification and quantitation of the analytes on LC/MS/MS. This assay offers advantages of specificity, speed and greater sensitivity over the previously developed HPLC-UV assay. The lower limit of quantitation is 500 ng ml −1 for vesnarinone and 20 ng ml −1 for OPC-8230, OPC-18137, and OPC-18136 in plasma. Methodology is similar for the estimation of these analytes in urine with the lower limit of quantitation being 500 ng ml −1 for vesnarinone and 100 ng ml −1 for each metabolite. Ascorbic acid was added to stabilize the analytes from degradation. This LC/MS/MS method was developed to overcome many practical problems associated with the HPLC method. The LC/MS/MS method offers the flexibility of analyzing additional metabolites and changing the linearity range to accommodate the differences in linear range (200–10 000 ng ml −1 for vesnarinone and 20–1000 for metabolites) for the analytes.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(98)00194-0</identifier><identifier>PMID: 9925340</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Biological and medical sciences ; Biotransformation ; Cardiotonic Agents - analysis ; Cardiotonic Agents - blood ; Cardiotonic Agents - urine ; Chromatography, Liquid ; General pharmacology ; Humans ; LC/MS/MS ; Mass Spectrometry ; Medical sciences ; Metabolites ; Parent ion ; Pharmacology. Drug treatments ; Product ion ; Quinolines - analysis ; Quinolines - blood ; Quinolines - urine ; Reproducibility of Results ; Spectrophotometry, Ultraviolet ; Vesnarinone</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 1999, Vol.18 (6), p.1037-1045</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3</citedby><cites>FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1677413$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9925340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tata, PrasadN.V.</creatorcontrib><creatorcontrib>Schorno, KarlS</creatorcontrib><creatorcontrib>Cowart, T.Douglas</creatorcontrib><creatorcontrib>Bramer, StevenL</creatorcontrib><title>LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>An LC/MS/MS assay was developed and successfully used to quantitate vesnarinone and its principal metabolites (OPC-8230, OPC-18136, and OPC-18137) in human plasma and urine. Samples were pre-treated with liquid–solid extraction followed by simultaneous monitoring of primary and daughter ions which were used for the identification and quantitation of the analytes on LC/MS/MS. This assay offers advantages of specificity, speed and greater sensitivity over the previously developed HPLC-UV assay. The lower limit of quantitation is 500 ng ml −1 for vesnarinone and 20 ng ml −1 for OPC-8230, OPC-18137, and OPC-18136 in plasma. Methodology is similar for the estimation of these analytes in urine with the lower limit of quantitation being 500 ng ml −1 for vesnarinone and 100 ng ml −1 for each metabolite. Ascorbic acid was added to stabilize the analytes from degradation. This LC/MS/MS method was developed to overcome many practical problems associated with the HPLC method. The LC/MS/MS method offers the flexibility of analyzing additional metabolites and changing the linearity range to accommodate the differences in linear range (200–10 000 ng ml −1 for vesnarinone and 20–1000 for metabolites) for the analytes.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Cardiotonic Agents - analysis</subject><subject>Cardiotonic Agents - blood</subject><subject>Cardiotonic Agents - urine</subject><subject>Chromatography, Liquid</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>LC/MS/MS</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Metabolites</subject><subject>Parent ion</subject><subject>Pharmacology. Drug treatments</subject><subject>Product ion</subject><subject>Quinolines - analysis</subject><subject>Quinolines - blood</subject><subject>Quinolines - urine</subject><subject>Reproducibility of Results</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Vesnarinone</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLxDAQgIMouj5-gtCDiB6qkyZpm5PI4gtWBFfBW8gmU4j0sXa6wv57sw_0KASGZL6ZzHyMnXK44sDz6ykUgqcFlOpCl5cAXMsUdtiIl4VIs1x-7LLRL3LADok-AUBFbJ_ta50pIWHEXifj6-dpPIltbb2kQElXJd9Ire1D27UY330SBkrm8e7C3NZJg4OddXUYkJLQJvPaUmPX3CIyeMz2KlsTnmzjEXu_v3sbP6aTl4en8e0kdVKpIZWIPi7CRSYhdwJ9Jb0q0Tm0yAtQHjBTlfPSZui0mAnlUOeZ0qUtBGgnjtj5pu-8774WSINpAjmsa9tityCTa5XrLC8jqDag6zuiHisTd2lsvzQczMqlWbs0K1FGl2bt0kCsO91-sJg16H-rtvJi_mybt-RsXfU2CqK_5nlRSC4idrPBMMr4DtgbcgFbhz706Abju_DPID_ag5BF</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Tata, PrasadN.V.</creator><creator>Schorno, KarlS</creator><creator>Cowart, T.Douglas</creator><creator>Bramer, StevenL</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine</title><author>Tata, PrasadN.V. ; Schorno, KarlS ; Cowart, T.Douglas ; Bramer, StevenL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Cardiotonic Agents - analysis</topic><topic>Cardiotonic Agents - blood</topic><topic>Cardiotonic Agents - urine</topic><topic>Chromatography, Liquid</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>LC/MS/MS</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Metabolites</topic><topic>Parent ion</topic><topic>Pharmacology. Drug treatments</topic><topic>Product ion</topic><topic>Quinolines - analysis</topic><topic>Quinolines - blood</topic><topic>Quinolines - urine</topic><topic>Reproducibility of Results</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Vesnarinone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tata, PrasadN.V.</creatorcontrib><creatorcontrib>Schorno, KarlS</creatorcontrib><creatorcontrib>Cowart, T.Douglas</creatorcontrib><creatorcontrib>Bramer, StevenL</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tata, PrasadN.V.</au><au>Schorno, KarlS</au><au>Cowart, T.Douglas</au><au>Bramer, StevenL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>1999</date><risdate>1999</risdate><volume>18</volume><issue>6</issue><spage>1037</spage><epage>1045</epage><pages>1037-1045</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>An LC/MS/MS assay was developed and successfully used to quantitate vesnarinone and its principal metabolites (OPC-8230, OPC-18136, and OPC-18137) in human plasma and urine. Samples were pre-treated with liquid–solid extraction followed by simultaneous monitoring of primary and daughter ions which were used for the identification and quantitation of the analytes on LC/MS/MS. This assay offers advantages of specificity, speed and greater sensitivity over the previously developed HPLC-UV assay. The lower limit of quantitation is 500 ng ml −1 for vesnarinone and 20 ng ml −1 for OPC-8230, OPC-18137, and OPC-18136 in plasma. Methodology is similar for the estimation of these analytes in urine with the lower limit of quantitation being 500 ng ml −1 for vesnarinone and 100 ng ml −1 for each metabolite. Ascorbic acid was added to stabilize the analytes from degradation. This LC/MS/MS method was developed to overcome many practical problems associated with the HPLC method. The LC/MS/MS method offers the flexibility of analyzing additional metabolites and changing the linearity range to accommodate the differences in linear range (200–10 000 ng ml −1 for vesnarinone and 20–1000 for metabolites) for the analytes.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>9925340</pmid><doi>10.1016/S0731-7085(98)00194-0</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 1999, Vol.18 (6), p.1037-1045
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_69569268
source Elsevier
subjects Analysis
Biological and medical sciences
Biotransformation
Cardiotonic Agents - analysis
Cardiotonic Agents - blood
Cardiotonic Agents - urine
Chromatography, Liquid
General pharmacology
Humans
LC/MS/MS
Mass Spectrometry
Medical sciences
Metabolites
Parent ion
Pharmacology. Drug treatments
Product ion
Quinolines - analysis
Quinolines - blood
Quinolines - urine
Reproducibility of Results
Spectrophotometry, Ultraviolet
Vesnarinone
title LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T19%3A57%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LC/MS/MS%20analysis%20of%20vesnarinone%20and%20its%20principal%20metabolites%20in%20plasma%20and%20urine&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Tata,%20PrasadN.V.&rft.date=1999&rft.volume=18&rft.issue=6&rft.spage=1037&rft.epage=1045&rft.pages=1037-1045&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(98)00194-0&rft_dat=%3Cproquest_cross%3E69569268%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-4eed101132406c3edf4d58ecceae1705d0e25fcd4a2ec93b35ce962598a7309c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69569268&rft_id=info:pmid/9925340&rfr_iscdi=true